Company No: 11486993 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	2025		2024
		£		£
				Restated - note 2
Fixed assets
Tangible assets	4	174,204		190,312
		174,204		190,312
Current assets
Stocks		1,650		1,550
Debtors	5	1,211,061		259,524
Cash at bank and in hand		895,135		731,678
		2,107,846		992,752
Creditors: amounts falling due within one year	6	( 1,204,551)		( 581,691)
Net current assets		903,295		411,061
Total assets less current liabilities		1,077,499		601,373
Provision for liabilities		( 33,193)		( 34,997)
Net assets		1,044,306		566,376
Capital and reserves
Called-up share capital		100		100
Profit and loss account		1,044,206		566,276
Total shareholder's funds		1,044,306		566,376

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The member has not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Delamere Health Limited (registered number: 11486993) were approved and authorised for issue by the Director on 17 December 2025. They were signed on its behalf by:

M C Preston Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Delamere Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Forest Road, Cuddington, , Cheshire, CW8 2EH, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Prior year adjustment

During the preparation of the financial statements for the year ended 31 March 2025, adjustments were identified in relation to reclasses of amounts owed by ultimate parent and group companies from creditors to debtors for the prior year. As a result, the comparative figures for the year ended 31 March 2024 have been restated in these financial statements.

Please refer to Note 2 for further details of the adjustments recorded.

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
* the amount of revenue can be measured reliably;
* it is probable that the Company will receive the consideration due under the contract;
* the stage of completion of the contract at the end of the reporting period can be measured reliably; and
* the costs incurred and the costs to complete the contract can be measured reliably.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements	33 % reducing balance
Vehicles	33 % reducing balance
Fixtures and fittings	33 % reducing balance
Tools and equipment	33 % reducing balance
Computer equipment	33 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

2. Prior year adjustment

During the preparation of the financial statements for the year ended 31 March 2025, adjustments were identified to correct errors in the prior year. As a result, the comparative figures for the year ended 31 March 2024 have been restated. These adjustments are summarised below:

Amount owed by undertakings reclassed
Amounts owed by group undertakings were incorrectly recognised within creditors in the year ended 31 March 2024. An adjustment has been made to reclass the debit balances to debtors.

The net impact of these adjustments have no impact on profit after tax or net assets as at 31 May 2024.

During the year, a reclassification has been made between administrative expenses and cost of sales. This adjustment was made to more accurately present the nature of the underlying costs. The reclassification has no effect on the reported profit or net assets for the current or prior periods.

		As previously reported		Adjustment		As restated
Year ended 31 March 2024		£		£		£
Other creditors - amount owed to group undertakings		63,964		(99,921)		(35,957)
Other debtors - amount owed by ultimate parent		56,087		50,128		106,215
Other debtors - amount owed by group undertakings		0		49,793		49,793
COS		247,702		1,169,127		1,416,829
Admin expenses		3,144,009		(1,169,127)		1,974,882

3. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including the director	48		43

4. Tangible assets

	Leasehold improve- ments		Vehicles		Fixtures and fittings		Tools and equipment		Computer equipment		Total
	£		£		£		£		£		£
Cost
At 01 April 2024	30,798		34,980		410,073		96,763		87,581		660,195
Additions	0		0		31,698		839		26,068		58,605
Disposals	0		0		( 2,169)		( 8,454)		( 28,718)		( 39,341)
At 31 March 2025	30,798		34,980		439,602		89,148		84,931		679,459
Accumulated depreciation
At 01 April 2024	21,815		( 5,096)		330,945		70,657		51,562		469,883
Charge for the financial year	2,964		13,227		26,981		8,245		15,153		66,570
Disposals	0		0		( 1,689)		( 7,149)		( 22,360)		( 31,198)
At 31 March 2025	24,779		8,131		356,237		71,753		44,355		505,255
Net book value
At 31 March 2025	6,019		26,849		83,365		17,395		40,576		174,204
At 31 March 2024	8,983		40,076		79,128		26,106		36,019		190,312

5. Debtors

	2025		2024
	£		£
Trade debtors	63,716		35,531
Amounts owed by Group undertakings	639,707		49,793
Amounts owed by Ultimate Parent undertakings	361,418		50,128
Other debtors	146,220		124,072
	1,211,061		259,524

6. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	177,707		105,204
Amounts owed to Group undertakings	240,027		35,957
Taxation and social security	523,452		274,237
Other creditors	263,365		166,293
	1,204,551		581,691

7. Financial commitments

Pensions

The Company operates a defined contribution pension scheme for the director and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

	2025		2024
	£		£
Unpaid contributions due to the fund (inc. in other creditors)	7,531		4,735

8. Related party transactions

Transactions with the entity's director

During the year a director was advanced £36,952 (2024: £37,622) by the company and repaid £74,570 (2024: £nil). No interest is charged (2024: £nil). At the year end amounts owing to the company from the director amounted to £nil (2024: £37,622). The maximum outstanding in the year was £36,952 (2024: £37,622).

9. Ultimate controlling party

The ultimate parent company is Delamere Health Group Holdings Limited, a company registered in England and Wales, company number 14603126, which owns 100% of the called up share capital.

The ultimate controlling party is Mr M C Preston, a director, by virtue of his majority shareholding in Delamere Health Group Holdings Limited.